image
AbCellera Biologics Inc. ABCL
Healthcare - Biotechnology - NASDAQ - CA
Watchlist
$ 3.41
-1.73 %
$ 1.02 B
Market Cap
-6.09
P/E
Price Target Average
214.20%
Revenue Forecast Estimate
63.04%
EBIT Estimate
59.66%
Net Income Estimate
36.49%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets AbCellera Biologics Inc.
image
Wall Street analysts predict an average 1-year price target for ABCL of $10.7 , with forecasts ranging from a low of $5 to a high of $30 .
ABCL Lowest Price Target Wall Street Target
5 USD 46.63%
ABCL Average Price Target Wall Street Target
10.7 USD 214.20%
ABCL Highest Price Target Wall Street Target
30 USD 779.77%
Price
Max Price Target
Min Price Target
Average Price Target
303025252020151510105500Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart ABCL

image
$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.020202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ABCL

image
$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)20202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ABCL

image
$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)20202020202120212022202220232023202420242025202520262026202720272028202820292029